4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000096
Options or other derivatives
- Director acquired 4,411 shares (grant or award)
- Director returned 15,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Nielsen Jack · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-27 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −15,000 | 0 | D |
| 2024-02-28 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +4,411 | 4,411 | D |
Loading xslF345X05/form4.xml…